Clopidogrel Response in Acute Ischemic Stroke. The Bochumer CRISP Study

Prevalence of Low Response to Clopidogrel in Patients After Acute Ischemic Stroke.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01843361

Acronym

Bo-CRISP

Enrollment

159

Registered

2013-04-30

Start date

2010-07-31

Completion date

2012-12-31

Last updated

2013-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Stroke

Keywords

Stroke, Clopidogrel, Aggregometry, Antiplatelet therapy, Platelet function tests

Brief summary

The aim of this study was to determine the prevalence rate and risk factors for chemical laboratory clopidogrel low-response (CLR) in the acute phase after an ischemic stroke.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* acute ischemic stroke * admittance to stroke unit * clopidogrel medication

Exclusion criteria

* no consent * prior bleeding disorders * severe liver disorders * current gastrointestinal disorders * congestive heart failure * life-threatening malignancies

Design outcomes

Primary

Measure	Time frame	Description
Result of platelet function test	one day	Aggregometry result of antiplatelet therapy

Countries

Germany

Outcome results